Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease) (VOC-BPCO)
Sponsor: Air Liquide SA
Listed as NCT05029349, this NA trial focuses on Chronic Obstructive Pulmonary Disease Severe and remains ongoing. Sponsored by Air Liquide SA, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Feb 2022 — Feb 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Air Liquide SA
- Hopital Foch
For direct contact, visit the study record on ClinicalTrials.gov .